Shuhua Han
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Real-world effectiveness and safety of adebrelimab as first-line treatment in patients with extensive-stage small cell lung cancer.
Journal: Translational lung cancer research
Published: November 06, 2025
Endostar overcomes Osimertinib-resistance mediated EGFR-activation mutation, T790M and cis-C797S triple mutations via enhancing the binding of Osimertinib to EGFR protein.
Journal: Life sciences
Published: November 03, 2025
Enhanced therapeutic efficacy of repeated bone marrow-derived MSC administration in a murine model of pulmonary fibrosis.
Journal: Stem cell research & therapy
Published: August 29, 2025
How the Fibrotic Lung Microenvironment Regulates Stem Cell Behavior: Immune Cues, Extracellular Matrix Remodeling, and Therapeutic Implications.
Journal: Analytical cellular pathology (Amsterdam)
Published: June 24, 2025
Bionic gene delivery system activates tumor autophagy and immunosuppressive niche to sensitize anti-PD-1 treatment against STK11-mutated lung adenocarcinoma.
Journal: Journal of nanobiotechnology
Published: November 21, 2024
PERP May Affect the Prognosis of Lung Adenocarcinoma by Inhibiting Apoptosis.
Journal: Cancer management and research
Published: November 14, 2023
Successful treatment of a patient with NSCLC carrying uncommon compound L861Q/G719X epidermal growth factor receptor mutations using Afatinib.
Journal: Respiratory medicine case reports
Published: August 10, 2023
MiR-1246b, a novel miRNA molecule of extracellular vesicles in bronchoalveolar lavage fluid, promotes nodule growth through FGF14 in patients with lung cancer.
Journal: Cell death & disease
Published: April 17, 2023
Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Expression via MET/STAT3/Akt Pathway.
Journal: Canadian respiratory journal
Published: December 05, 2022
Multiparameter prediction model of immune checkpoint inhibitors combined with chemotherapy for non-small cell lung cancer based on support vector machine learning.
Journal: Scientific reports
Published: November 14, 2022
A Classifier for Improving Early Lung Cancer Diagnosis Incorporating Artificial Intelligence and Liquid Biopsy.
Journal: Frontiers in oncology
Published: January 13, 2022
Last Updated: 09/26/2026